Hemodynamic Monitoring Systems Market

Hemodynamic Monitoring Systems Market by Product (Disposables and Monitors), Type (Invasive, Minimally Invasive, and Non-invasive), End User (Hospitals, Clinics & Ambulatory Care Center, and Home Care Setting), and Region - Global Forecasts to 2023

Report Code: MD 3211 Aug, 2018, by marketsandmarkets.com

[149 Pages Report] The hemodynamic monitoring systems market is expected to reach USD 1,167.4 million by 2023 from USD 806.5 million in 2017, at a CAGR of 6.4% during the forecast period. Base year considered for the report is 2017 and the forecast period considered for this report is 2018–2023. Technological advancements in hemodynamic monitoring systems, increasing research into hemodynamic monitoring systems, influx of VC funding, rising prevalence of cardiovascular diseases & diabetes, and government focus on critical care infrastructure & services are expected to drive the growth of the market. However, the risk associated with invasive hemodynamic monitoring, such as sepsis, bleeding, hemorrhage, thrombosis, air embolism, and pulmonary capillary necrosis is expected to restrain the growth of this market to a certain extent.

Hemodynamic Monitoring Systems Market Dynamics

Hemodynamic Monitoring Systems Market Drivers

  • Technological advancements in hemodynamic monitoring systems
  • Increasing research into hemodynamic monitoring systems
  • Influx of VC funding
  • Rising prevalence of cardiovascular diseases  and diabetes
  • Rising geriatric population and growing number of surgeries
  • Awareness initiatives by industry players
  • Government focus on critical care infrastructure and services

Hemodynamic Monitoring Systems Market Restraints

  • Risks associated with invasive hemodynamic monitoring

Hemodynamic Monitoring Systems Market Opportunities

  • Emerging markets
  • Growing demand for patient monitoring devices in non-hospital settings

Hemodynamic Monitoring Systems Market Challenges

  • Increasing pricing pressure on market players
  • Limited patient awareness related to disease diagnosis
  • Dearth of skilled professionals

Technological advancements in hemodynamic monitoring systems

Recent years have witnessed a growing preference for noninvasive technologies from traditionally accepted invasive techniques.

Noninvasive hemodynamic monitoring systems facilitate painless diagnosis and reduce the risk of blood-borne infections in patients. In addition, these systems are easier to use (as compared to invasive systems) and can be operated by a nurse in the absence of a specialist/doctor. Owing to this advantage, the hemodynamic state can be simultaneously monitored in numerous patients, which results in a reduction in staff costs as well as treatment expenses. These advantages are expected to increase the market for noninvasive systems in the coming years.

Microelectromechanical Systems (MEMS)

These are miniaturized devices, of sizes ranging from several millimeters to one micron. These elements permit the construction of small sensor chips, allowing for minimally invasive insertions. MEMS pressure sensors are used for determining the hemodynamic profile of patients. The CardioMEMS Champion Heart Failure Monitoring System from St. Jude Medical (US) is one product in this market space.

Hypotension Prediction Index (HPI) software

HPI software leverages predictive analytics to alert clinicians to address potentially developing hypotension events before they occur. Edwards Lifesciences Corporation (US) is a key player in this market, with its FDA-approved Hypotension Prediction Index (HPI). This software sends an alarm when the HPI exceeds an upper threshold and features a secondary screen that visually links blood pressure with hemodynamic flow parameters. This provides a comprehensive view of the patient’s hemodynamic status to identify the root cause of low blood pressure.

Moreover, in April 2017, Caretaker Medical (US), in partnership with OBS Medical (UK), announced its Visensia safety index which enables advanced and the early detection of patients’ blood pressure and other vital signs (such as heart rate, respiration rate, and blood oxygen saturation) by collecting beat-by-beat blood pressure using the Caretaker wearable finger-cuff and processing this data via its AI.

The following are the major objectives of the Hemodynamic Monitoring Systems Market Research study

  • To define, measure, and describe the global market by product, type, end user, and region
  • To provide detailed information about the major factors influencing market growth (drivers, restraints, challenges, and opportunities)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of market segments in North America, Europe, Asia Pacific, and RoW
  • To strategically analyze the market structure and profile key players in the global market and comprehensively analyze their core competencies
  • To track and analyze company developments such as partnerships, agreements, and collaborations; expansions; product approvals; and product launches in the market

During this research study, major players operating in the hemodynamic monitoring systems market in various regions have been identified, and their offerings, and their have been analyzed through in-depth discussions.

Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as the International Hemodynamic Society (IHS), Association for the Advancement of Medical Instrumentation (AAMI), New York Heart Association (NYHA), Department of Anesthesiology & Perioperative Care (University of California), National Institute on Aging (NIA), International Diabetes Federation (IDF), American Association of Critical-Care Nurses (AACN), Intensive Care National Audit & Research Centre (ICNARC), American College of Cardiology (ACC), Society of Critical Care Medicine, Canadian Critical Care Society, European Society of Intensive Care Medicine, International Sepsis Forum, Japanese Society of Intensive Care Medicine, directories, industry journals, databases, press releases, and annual reports of the companies have been used to identify and collect information useful for the study of this market.

Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess the dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

Hemodynamic Monitoring Systems Market

To know about the assumptions considered for the study, download the pdf brochure

The major players in the global hemodynamic monitoring systems market are Edwards Lifesciences Corporation (US), PULSION Medical Systems SE (Germany), LiDCO Group plc (UK), Cheetah Medical (Israel), Deltex Medical Group Plc. (UK), ICU Medical (US), Osypka Medical GmbH (Germany), CareTaker Medical (US), CNSystems (Austria), NI Medical (Israel), and Uscom (Australia).

Hemodynamic Monitoring Systems Major Market Developments:

  • In May 2017, Caretaker Medical entered into a partnership with OBS Medical (UK), a global leader in the development of predictive algorithms for identifying critical instabilities in acute settings and emerging alternative treatment locations.. The partnership was aimed to integrate data from CareTaker’s simple finger cuff into the Visensia Platform offered by OBS Medical to advance the early detection of patient health deterioration.
  • In July 2016, Cheetah Medical entered into an agreement with Allina Health (US), to provide Allina Health access to Cheetah Medical’s hemodynamic monitoring solutions to guide volume management decisions in septic patients across the Allina Health hospital network.
  • In May 2016, LiDCO Group entered into an agreement with ICU Medical (US) to sell the LiDCO IM, a noninvasive hemodynamic monitoring system, in the US. 
  • In January 2015, CNSystems entered into a partnership with the Sage Group Inc (US) to further commercialize its noninvasive continuous hemodynamic monitoring systems into a wider range of markets.

Target Audience for Hemodynamic Monitoring Systems Market Research Report:

  • Hemodynamic monitoring system and disposables manufacturers
  • Suppliers and distributors of hemodynamic monitoring systems and disposables
  • Government bodies/municipal corporations
  • Regulatory bodies
  • Healthcare service providers
  • Health insurance players
  • Catheterization laboratories (Cath labs)
  • Teaching hospitals and academic medical centers (AMCs)
  • Home and ambulatory sites
  • Medical research institutes
  •  Venture capitalists
  • Community centers
  • Regulatory bodies
  • Market research and consulting firms

Scope of the Report

The research report categorizes the hemodynamic monitoring systems market into the following segments and subsegments:

Hemodynamic Monitoring Systems Market by Product

  • Monitors
  • Disposables

Hemodynamic Monitoring Systems Market by Type

  • Invasive
  • Minimally invasive
  • Noninvasive

Hemodynamic Monitoring Systems Market by End User

  • Hospitals
  • Clinics and ambulatory care centers
  • Home care settings

Hemodynamic Monitoring Systems Market by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Rest of Europe (RoE)
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific (RoAPAC)
  • Rest of the World

Critical Questions which the report answers:

  • Which are the key players in the market and how intense is the competition?
  • What are new technological developments in the market?

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of each company

Company Information

  • Detailed analysis and profiling of additional market players (up to 3)

The global hemodynamic monitoring systems market is expected to reach USD 1,167.4 million by 2023 from USD 857.8 million in 2018, at a CAGR of 6.4% during the forecast period. The growth of this market is primarily driven by factors such as the technological advancements in hemodynamic monitoring systems, increasing research into hemodynamic monitoring systems, influx of VC funding, and the rising prevalence of cardiovascular diseases & diabetes.

The market is segmented on the basis of product, type, end user, and region.

By product, the market is segmented into two broad categories—monitors and disposables. In 2018, the disposables segment is expected to account for the largest share of the market. This can be attributed to the presence of a large patient population undergoing diagnosis for vascular diseases; increasing adoption of disposables among medical professionals owing to their procedural and technological benefits; and ongoing technological advancements in catheters, probes, sensors, and guidewires. Furthermore, the rising incidence of risk factors for vascular diseases (such as obesity, hypertension, alcoholism, and diabetes) is also expected to support the growth of this market segment during the forecast period.

By type, the global market is segmented into invasive, minimally invasive, and noninvasive hemodynamic monitoring systems. The invasive hemodynamic monitoring systems segment is estimated to account for the largest share of the global market in 2018. Invasive hemodynamic monitoring provides accurate, continuous, and comprehensive data on the hemodynamic state of a patient.

On the basis of end user, the global market is segmented into hospitals, clinics and ambulatory care centers (ACCs), and home care settings. In 2018, the hospitals segment is expected to account for the largest share of the global market. The large share of this segment can be attributed to the presence of big cath labs in hospitals, successful applications of hemodynamic monitoring systems in several procedures, increase in the prevalence of cardiovascular and other chronic diseases, and continuous technological advancements coupled with government funding.

Hemodynamic Monitoring Systems Market

The market is dominated by North America, followed by Europe, Asia Pacific, and the Rest of the World. North America is expected to dominate the market in 2018. Asia Pacific is expected to grow at a highest CAGR during the forecast period. Some of the factors driving market growth in the APAC region are Japan’s growing healthcare industry; extensive government reimbursement coverage for critical cardiac procedures; improving healthcare infrastructure in India and China; high diabetes prevalence in Vietnam, Singapore, Malaysia, China, and India; and government initiatives in Australia and Singapore.

Noninvasive hemodynamic systems form the fastest growing type segment of hemodynamic monitoring systems market

Invasive hemodynamic monitoring systems

Invasive hemodynamic monitoring systems are internal monitoring devices, that is, they are introduced into the body. Pulmonary artery catheters (PAC) are extensively used in invasive hemodynamic monitoring systems. They are considered as a gold standard to monitor useful hemodynamic data during cardiac surgeries and the postoperative period. However, this method is restricted for use in ICUs and is reserved for specific cases.

Invasive hemodynamic monitoring provides accurate, continuous, and comprehensive data on the hemodynamic state of a patient. However, the associated complications, such as arrhythmia, pulmonary artery rupture, infection, valve injury, knotting, and thrombosis, are restricting its use. These complications have compelled researchers to develop substitutes for invasive hemodynamic monitoring systems. Additionally, misinterpretation of data due to the lack of trained personnel and technical errors (such as loss of injectate, thermistor malfunction, variability of temperature, clot over catheter tip, and coiling of the catheter) can result in inaccurate readings.

Minimally hemodynamic monitoring systems

Minimally invasive hemodynamic monitoring systems have gained popularity over invasive hemodynamic monitoring systems due to their less invasive nature and ease of usage. These systems play a preliminary role in the perioperative management of high-risk factors. Minimally invasive hemodynamic monitoring encompasses all the methods and devices that calculate the cardiac output without the need of inserting a PAC.

Minimally invasive hemodynamic monitoring systems help decrease the length of patient stay, lower the risk of infections, and decrease the rate of morbidity and mortality, thus decreasing the expenditure towards patient care. Moreover, limitations of traditional invasive hemodynamic monitoring and the risk of associated complications are the key factors driving the uptake of minimally invasive hemodynamic monitoring systems. Also, the increased inclination towards the use of minimally invasive hemodynamic determination to guide organ perfusion and fluid therapy has changed the clinical demands of hemodynamic monitoring systems.

Noninvasive hemodynamic monitoring systems

Noninvasive hemodynamic monitoring systems are specifically designed to overcome the risk factors associated with invasive monitoring procedures. These systems are very effective in the continuous monitoring of patients under critical care (with a high heart rate and blood pressure). These systems use technologies such as finger cuffs and the pulse contour method. For instance, the ClearSight system offered by Edwards Lifesciences (US) comprises a finger cuff and the EV1000 clinical platform that is used for noninvasive blood pressure monitoring.

Noninvasive hemodynamic monitoring systems help in the painless diagnosis of diseases and reduce the risk of blood-borne infections in patients. Moreover, these systems are easier to use and master as compared to invasive systems (such as PACs), and hence can be operated by a nurse in the absence of a specialist/doctor. This ease-of-use enables the monitoring of the hemodynamic state in numerous patients, thus resulting in a reduction of the staffing costs, treatment expenses, and length of hospital stay. The rising incidence of respiratory disorders, increasing geriatric population, fewer complications of noninvasive hemodynamic monitoring as compared to invasive methods, better portability, ease of use, and better precision are the major factors driving the growth of this market segment.

Critical questions the report answers:

  • Which product market will dominate in future?
  • Emerging countries have immense opportunities for the growth of hemodynamic monitoring systems, will this scenario continue?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

The key players in the global hemodynamic monitoring systems market are Edwards Lifesciences Corporation (US), PULSION Medical Systems SE (Germany), LiDCO Group plc (UK), Cheetah Medical (Israel), Deltex Medical Group Plc. (UK), ICU Medical (US), Osypka Medical GmbH (Germany), CareTaker Medical (US), CNSystems (Austria), NI Medical (Israel), and Uscom (Australia).

Table of Contents

1 Introduction (Page No. - 16)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Years Considered for the Study
           1.3.2 Markets Covered
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 20)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation Methodology
    2.3 Market Data Validation and Triangulation
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 31)

4 Premium Insights (Page No. - 36)
    4.1 Market Overview
    4.2 Asia Pacific: Market, By Country and End User
    4.3 Geographic Snapshot: Global Market
    4.4 Global Market, By Type (2018 vs 2023)

5 Market Overview (Page No. - 40)
    5.1 Introduction
    5.2 Market Dynamics
    5.3 Drivers
           5.3.1 Technological Advancements in Hemodynamic Monitoring Systems
                    5.3.1.1 Microelectromechanical Systems (MEMS)
                    5.3.1.2 Hypotension Prediction Index (HPI) Software
           5.3.2 Increasing Research Into Hemodynamic Monitoring Systems
           5.3.3 Influx of VC Funding
           5.3.4 Rising Prevalence of Cardiovascular Diseases and Diabetes
           5.3.5 Rising Geriatric Population and Growing Number of Surgeries
           5.3.6 Awareness Initiatives By Industry Players
           5.3.7 Government Focus on Critical Care Infrastructure and Services
    5.4 Restraints
           5.4.1 Risks Associated With Invasive Hemodynamic Monitoring
    5.5 Opportunities
           5.5.1 Emerging Markets
           5.5.2 Growing Demand for Patient Monitoring Devices in Non-Hospital Settings
    5.6 Challenges
           5.6.1 Increasing Pricing Pressure on Market Players
           5.6.2 Limited Patient Awareness Related to Disease Diagnosis
           5.6.3 Dearth of Skilled Professionals

6 By Product (Page No. - 50)
    6.1 Introduction
    6.2 Disposables
    6.3 Monitors

7 By Type (Page No. - 58)
    7.1 Introduction
    7.2 Invasive Hemodynamic Monitoring Systems
    7.3 Minimally Invasive Hemodynamic Monitoring Systems
    7.4 Noninvasive Hemodynamic Monitoring Systems

8 By End User (Page No. - 68)
    8.1 Introduction
    8.2 Hospitals
    8.3 Clinics and Ambulatory Care Centers
    8.4 Home Care Settings

9 By Region (Page No. - 78)
    9.1 Introduction
    9.2 North America
           9.2.1 US
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 UK
           9.3.3 France
           9.3.4 RoE
    9.4 Asia Pacific
           9.4.1 Japan
           9.4.2 China
           9.4.3 India
           9.4.4 RoAPAC
    9.5 RoW

10 Competitive Landscape (Page No. - 114)
     10.1 Introduction
     10.2 Market Share Analysis
             10.2.1 Edwards Lifesciences Corporation
             10.2.2 Pulsion Medical Systems Se
             10.2.3 Lidco Group PLC
     10.3 Market Share Analysis, By Region
     10.4 Competitive Scenario

11 Company Profiles (Page No. - 122)
(Business Overview, Strength of Service Portfolio, Business Strategy Excellence, and Key Relationships)*
     11.1 Edwards Lifesciences Corporation
     11.2 Pulsion Medical Systems Se (Part of the Maquet Getinge Group)
     11.3 Lidco Group
     11.4 Deltex Medical Group PLC
     11.5 ICU Medical
     11.6 Cnsystems Medizintechnik GmbH
     11.7 Caretaker Medical
     11.8 Osypka Medical GmbH
     11.9 Cheetah Medical
     11.10 NI Medical
     11.11 Uscom

*Details on Business Overview, Strength of Service Portfolio, Business Strategy Excellence, and Key Relationships Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 142)
     12.1 Discussion Guide: Hemodynamic Monitoring Systems Market
     12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.3 Available Customizations
     12.4 Related Reports
     12.5 Author Details


List of Tables (91 Tables)

Table 1 Indicative List of Companies That Received Venture Capitalist Funding for the Hemodynamic Monitoring Systems Segment
Table 2 Top Five Countries With the Highest Number of Diabetics (Aged 20–79 Years), 2015 vs 2040
Table 3 Population Aged 60 Years and Over, By Region (In Million)
Table 4 Awareness Initiatives in 2017–2018
Table 5 By Product, 2016–2023 (USD Million)
Table 6 Types of Disposables Used in Hemodynamic Monitoring
Table 7 Hemodynamic Monitoring Disposables Market, By Region, 2016–2023 (USD Million)
Table 8 North America: Hemodynamic Monitoring Market for Disposables, By Country, 2016–2023 (USD Million)
Table 9 Europe: Hemodynamic Monitoring Market for Disposables, By Country, 2016–2023 (USD Million)
Table 10 Asia Pacific: Hemodynamic Monitoring Market for Disposables, By Country, 2016–2023 (USD Million)
Table 11 Types of Hemodynamic Monitors
Table 12 Hemodynamic Monitors Market, By Region, 2016–2023 (USD Million)
Table 13 North America: Hemodynamic Monitors Market, By Country, 2016–2023 (USD Million)
Table 14 Europe: Hemodynamic Monitors Market, By Country, 2016–2023 (USD Million)
Table 15 Asia Pacific: Hemodynamic Monitors Market, By Country, 2016–2023 (USD Million)
Table 16 Market, By Type, 2016–2023 (USD Million)
Table 17 Invasive Hemodynamic Monitoring Systems Market, By Region, 2016–2023 (USD Million)
Table 18 North America: Invasive Hemodynamic Monitoring Systems Market, By Country, 2016–2023 (USD Million)
Table 19 Europe: Invasive Market, By Country, 2016–2023 (USD Million)
Table 20 Asia Pacific: Invasive Market, By Country, 2016–2023 (USD Million)
Table 21 Minimally Invasive Market, By Region, 2016–2023 (USD Million)
Table 22 North America: Minimally Invasive Hemodynamic Monitoring Systems Market, By Country, 2016–2023 (USD Million)
Table 23 Europe: Minimally Invasive Market, By Country, 2016–2023 (USD Million)
Table 24 Asia Pacific: Minimally Invasive Market, By Country, 2016–2023 (USD Million)
Table 25 Noninvasive Market, By Region, 2016–2023 (USD Million)
Table 26 North America: Noninvasive Market, By Country, 2016–2023 (USD Million)
Table 27 Europe: Noninvasive Market, By Country, 2016–2023 (USD Million)
Table 28 Asia Pacific: NoninvasiveMarket, By Country, 2016–2023 (USD Million)
Table 29 By End User, 2016–2023 (USD Million)
Table 30 Market for Hospitals, By Region, 2016–2023 (USD Million)
Table 31 North America: Market for Hospitals, By Country, 2016–2023 (USD Million)
Table 32 Europe: Market for Hospitals, By Country, 2016–2023 (USD Million)
Table 33 Asia Pacific: Market for Hospitals, By Country, 2016–2023 (USD Million)
Table 34 Market for Clinics and Ambulatory Care Centers, By Region, 2016–2023 (USD Million)
Table 35 North America: Market for Clinics and Ambulatory Care Centers, By Country, 2016–2023 (USD Million)
Table 36 Europe: Market for Clinics and Ambulatory Care Centers, By Country, 2016–2023 (USD Million)
Table 37 Asia Pacific: Market for Clinics and Ambulatory Care Centers, By Country, 2016–2023 (USD Million)
Table 38 Market for Hemodynamic Monitoring Systems by Home Care Settings, By Region, 2016–2023 (USD Million)
Table 39 North America: Market for Home Care Settings, By Country, 2016–2023 (USD Million)
Table 40 Europe: Market for Home Care Settings, By Country, 2016–2023 (USD Million)
Table 41 Asia Pacific: Market for Hemodynamic Monitoring Systems by Home Care Settings, By Country, 2016–2023 (USD Million)
Table 42 Hemodynamic Monitoring Systems Market By Region, 2016–2023 (USD Million)
Table 43 North America: Market, By Country, 2016–2023 (USD Million)
Table 44 North America: Market, By Product, 2016–2023 (USD Million)
Table 45 North America: Market, By Type, 2016–2023 (USD Million)
Table 46 North America: Market, By End User, 2016–2023 (USD Million)
Table 47 US: Market, By Product, 2016–2023 (USD Million)
Table 48 US: Market, By Type, 2016–2023 (USD Million)
Table 49 US: Market, By End User, 2016–2023 (USD Million)
Table 50 Canada: Market, By Product, 2016–2023 (USD Million)
Table 51 Canada: Market, By Type, 2016–2023 (USD Million)
Table 52 Canada: Market, By End User, 2016–2023 (USD Million)
Table 53 Europe: Market, By Country, 2016–2023 (USD Million)
Table 54 Europe: Market, By Product, 2016–2023 (USD Million)
Table 55 Europe: Market, By Type, 2016–2023 (USD Million)
Table 56 Europe: Market, By End User, 2016–2023 (USD Million)
Table 57 Germany: Market, By Product, 2016–2023 (USD Million)
Table 58 Germany: Market, By Type, 2016–2023 (USD Million)
Table 59 Germany: Market, By End User, 2016–2023 (USD Million)
Table 60 UK: Market, By Product, 2016–2023 (USD Million)
Table 61 UK: Market, By Type, 2016–2023 (USD Million)
Table 62 UK: Market, By End User, 2016–2023 (USD Million)
Table 63 France: Hemodynamic Monitoring Systems Market, By Product, 2016–2023 (USD Million)
Table 64 France: Market, By Type, 2016–2023 (USD Million)
Table 65 France: Market, By End User, 2016–2023 (USD Million)
Table 66 RoE: Hemodynamic Monitoring Systems Market, By Product, 2016–2023 (USD Million)
Table 67 RoE: Market, By Type, 2016–2023 (USD Million)
Table 68 RoE: Market, By End User, 2016–2023 (USD Million)
Table 69 Prominent Research Projects Focusing on Hemodynamic Monitoring
Table 70 Asia Pacific: Hemodynamic Monitoring Systems Market, By Country, 2016–2023 (USD Million)
Table 71 Asia Pacific: Market, By Product, 2016–2023 (USD Million)
Table 72 Asia Pacific: Market, By Type, 2016–2023 (USD Million)
Table 73 Asia Pacific: Market, By End User, 2016–2023 (USD Million)
Table 74 Japan: Hemodynamic Monitoring Systems Market, By Product, 2016–2023 (USD Million)
Table 75 Japan: Market, By Type, 2016–2023 (USD Million)
Table 76 Japan: Market, By End User, 2016–2023 (USD Million)
Table 77 China: Market, By Product, 2016–2023 (USD Million)
Table 78 China: Market, By Type, 2016–2023 (USD Million)
Table 79 China: Market, By End User, 2016–2023 (USD Million)
Table 80 India: Market, By Product, 2016–2023 (USD Million)
Table 81 India: Market, By Type, 2016–2023 (USD Million)
Table 82 India: Hemodynamic Monitoring Systems Market, By End User, 2016–2023 (USD Million)
Table 83 RoAPAC: Market, By Product, 2016–2023 (USD Million)
Table 84 RoAPAC: Market, By Type, 2016–2023 (USD Million)
Table 85 RoAPAC: Market, By End User, 2016–2023 (USD Million)
Table 86 RoW: Market, By Product, 2016–2023 (USD Million)
Table 87 RoW: Market, By Type, 2016–2023 (USD Million)
Table 88 RoW: Market, By End User, 2016–2023 (USD Million)
Table 89 Product Launches and Product Enhancements, 2015-2018
Table 90 Agreements, Collaborations, and Partnerships
Table 91 Other Developments


List of Figures (36 Figures)

Figure 1 Market Segmentation
Figure 2 Research Methodology
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Market Size Estimation Methodology: Top-Down Approach
Figure 6 Research Design
Figure 7 Data Triangulation Methodology
Figure 8 Monitors Segment to Witness the Highest Growth in the Forecast Period
Figure 9 By Type, 2018 vs 2023
Figure 10 Hospitals Segment to Account for the Largest Share of the global Market in 2018
Figure 11 Asia Pacific to Register the Highest CAGR in the Forecast Period
Figure 12 Technological Advancements in Hemodynamic Monitoring Sytems is the Key Factor Driving the Growth of the Market
Figure 13 Hospitals Segment to Dominate the Market in 2018
Figure 14 Asia Pacific to Witness the Highest Growth Rate During the Forecast Period
Figure 15 Invasive Systems Segment to Command the Largest Market Share By 2023
Figure 16 Percentage Change in Population Aged 60 Years and Over, By Region (2000–2030)
Figure 17 By Product, 2018 vs 2023 (USD Million)
Figure 18 By Type, 2018 vs 2023
Figure 19 By End User, 2018 vs 2023 (USD Million)
Figure 20 By Region, 2018 vs 2023
Figure 21 North America: Market Snapshot
Figure 22 Europe: Market Snapshot
Figure 23 Asia Pacific: Market Snapshot
Figure 24 RoW: Market Snapshot
Figure 25 Key Developments in the Market Between 2015 and 2018
Figure 26 Market Share Analysis, By Key Player, 2017
Figure 27 North America: Market Share Analysis, By Key Player, 2017
Figure 28 Europe: Market Share Analysis, By Key Player, 2017
Figure 29 Asia Pacific: Market Share Analysis, By Key Player, 2017
Figure 30 RoW: Market Share Analysis, By Key Player, 2017
Figure 31 Geographic Presence of Key Players
Figure 32 Edwards Lifesciences Corporation: Company Snapshot (2017)
Figure 33 Pulsion Medical Systems Se: Company Snapshot (2017)
Figure 34 Lidco Group: Company Snapshot (2017)
Figure 35 Deltex Medical Group PLC: Company Snapshot (2017)
Figure 36 ICU Medical: Company Snapshot (2017)


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 3211
Published ON
Aug, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Hemodynamic Monitoring Systems Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved